Global Information
회사소개 | 문의 | 위시리스트

세계의 심장재동기화 치료(CRT) 시장 예측(-2024년) : 제품 종류별(제세동기, 페이스메이커), 최종사용자별(병원, 심장 센터, 외래 외과 센터)

Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024

리서치사 MarketsandMarkets
발행일 2019년 04월 상품 코드 829740
페이지 정보 영문 108 Pages
가격
US $ 5,650 ₩ 6,691,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,875,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,652,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,843,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 심장재동기화 치료(CRT) 시장 예측(-2024년) : 제품 종류별(제세동기, 페이스메이커), 최종사용자별(병원, 심장 센터, 외래 외과 센터) Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024
발행일 : 2019년 04월 페이지 정보 : 영문 108 Pages

세계의 심장재동기화 치료 시장은 2019년 41억 달러에서 2024년 말까지 51억 달러에 달하고, CAGR 4.4%로 성장할 전망입니다. 고령화에 따른 표적 질환 발증률 상승, 기술 진보에 의한 투자와 지원 확대 등이 시장 성장에 기여하고 있습니다.

세계의 심장재동기화 치료(CRT : Cardiac Resynchronization Therapy) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장에 참여하는 기업 개요에 대해 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 기회
    • 과제

제6장 종류별 시장

  • 서론
  • 제세동기
  • 페이스메이커

제7장 최종사용자별 시장

  • 서론
  • 병원 및 심장 센터
  • 외래 외과 센터

제8장 지역별 시장

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제9장 경쟁 동향

  • 개요
  • 시장 점유율 분석
  • 경쟁 시나리오

제10장 기업 개요

제11장 부록

도표

KSM 19.05.09

LIST OF TABLES

  • TABLE 1: POPULATION STATISTICS, 2015 VS 2030 VS 2050 (MILLION INDIVIDUALS)
  • TABLE 2: LIST OF PRODUCT RECALLS
  • TABLE 3: BATTERY SURVIVAL RATE BY DEVICE MANUFACTURER
  • TABLE 4: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 7: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 9: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 10: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 14: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 16: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 19: CLINICAL TRIALS RELATED TO CARDIAC RESYNCHRONIZATION THERAPY DEVICES
  • TABLE 20: US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 22: CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 23: CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 24: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 26: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 29: GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 30: GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 31: RESEARCH STUDIES RELATED TO CRT DEVICES IN THE UK
  • TABLE 32: UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 34: FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 36: ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 39: ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 41: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 47: JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 48: CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 53: ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 56: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 58: PRODUCT LAUNCHES AND APPROVALS, 2017 - 2018
  • TABLE 59: EXPANSIONS, 2016

LIST OF FIGURES

  • FIGURE 1: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SEGMENTATION
  • FIGURE 2: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • FIGURE 9: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHIC SNAPSHOT: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, 2018
  • FIGURE 11: INCREASING INCIDENCE TARGET DISEASE TO DRIVE THE GROWTH OF THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET
  • FIGURE 12: DEFIBRILLATORS TO DOMINATE THE NORTH AMERICAN MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: CRT - DEFIBRILLATORS TO DOMINATE THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 16: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 17: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 18: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2019 VS. 2024
  • FIGURE 19: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 20: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 22: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 23: MARKET SHARE ANALYSIS BY KEY PLAYERS (2015-2018)
  • FIGURE 24: MEDTRONIC, PLC: COMPANY SNAPSHOT (2017)
  • FIGURE 25: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 26: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 27: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2017)

"The CRT market is projected to grow at a CAGR of 4.4% during the forecast period (2019-2024)."

The CRT market is projected to reach USD 5.1 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 4.4%. The growth of the CRT market is mainly driven by the increasing incidence of target disease and growth in the geriatric population. Rising investments and support, along with technological advancements, are also contributing to the growth of the market. However, unfavorable healthcare reforms in the US are expected to limit market growth to a certain extent.

"By product type, the cardiac resynchronization therapy defibrillators (CRT-D) segment accounted for the largest share of the market in 2018."

On the basis of product type, the CRT market is segmented into cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

"By end user, the hospitals & cardiac centers segment is expected to dominate the CRT market during the forecast period."

On the basis of end user, the CRT market is segmented into the hospitals & cardiac centers and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.

"APAC is expected to witness the highest growth during the forecast period."

The Asia Pacific region is projected to register the highest growth rate in the CRT systems market during the forecast period. Favorable reimbursement scenario in Japan, the rising geriatric population in China, rising incidence of CVDs, improving healthcare infrastructure, growing middle-class population, and rising disposable income levels in India are some of the key factors driving the growth of the CRT systems market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-55%, Tier 2-25%, and Tier 3-20%
  • By Designation: C-level-43%, Director-level-32%, and Others-25%
  • By Region: North America-38%, Europe-23%, Asia Pacific-29%, Rest of World-10%

The prominent players in the CRT market are: Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

Research Coverage:

The report analyzes the market for various cardiac resynchronization therapy (CRT) systems and their adoption pattern. It aims at estimating the market size and future growth potential of the CRT market and the different segments. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the CRT market
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the CRT market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global CRT market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the CRT market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • 4.3 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • 4.4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of target diseases
      • 5.2.1.2 Growth in the geriatric population
      • 5.2.1.3 Growing investments, funds, and grants
      • 5.2.1.4 Technological advancements
      • 5.2.1.5 MRI-safe device technology
      • 5.2.1.6 Wireless CRT
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable healthcare reforms in the US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled cardiac surgeons
      • 5.2.4.2 Product recalls
      • 5.2.4.3 Battery life and device replacement cost

6 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS
    • 6.2.1 CRT - DEFIBRILLATORS ACCOUNTED FOR THE LARGEST SHARE OF THE CRT SYSTEMS MARKET IN 2018
  • 6.3 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS
    • 6.3.1 THE CRT - PACEMAKERS MARKET WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CARDIAC CENTERS
    • 7.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET
  • 7.3 AMBULATORY SURGERY CENTERS
    • 7.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE THE ADOPTION OF CRT DEVICES

8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 Technological advancements-A key factor driving market growth
    • 8.2.2 CANADA
      • 8.2.2.1 Growing focus of government and private organizations on providing research funding is expected to drive the market in Canada
  • 8.3 EUROPE
    • 8.3.1 GERMANY
      • 8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth
    • 8.3.2 UK
      • 8.3.2.1 Increasing geriatric population and increasing use of CRT devices to drive market growth
    • 8.3.3 FRANCE
      • 8.3.3.1 Growing use of cardiac resynchronization therapy devices for heart failure to support market growth
    • 8.3.4 ITALY
      • 8.3.4.1 Increasing incidence of CVDs to drive the adoption of cardiac resynchronization therapy devices in the country
    • 8.3.5 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 JAPAN
      • 8.4.1.1 Favourable reimbursement policy to support market growth
    • 8.4.2 CHINA
      • 8.4.2.1 Growing geriatric population to drive the market for cardiac resynchronization therapy systems
    • 8.4.3 INDIA
      • 8.4.3.1 Growing middle-class population & rising disposable income levels are supporting the growth of the CRT systems market in India
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 MARKET SHARE ANALYSIS
    • 9.2.1 MEDTRONIC
    • 9.2.2 ABBOTT LABORATORIES
    • 9.2.3 BOSTON SCIENTIFIC CORPORATION
  • 9.3 COMPETITIVE SCENARIO
    • 9.3.1 PRODUCT LAUNCHES AND APPROVALS
    • 9.3.2 EXPANSIONS
    • 9.3.3 ACQUISITIONS, 2017 - 2018

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)*

  • 10.1 MEDTRONIC, PLC.
  • 10.2 ABBOTT LABORATORIES
  • 10.3 BOSTON SCIENTIFIC CORPORATION
  • 10.4 BIOTRONIK
  • 10.5 MEDICO S.P.A.
  • 10.6 MICROPORT SCIENTIFIC CORPORATION
  • Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q